TapImmune Inc. (OTCMKTS:TPIV) Takes Another Hit

[[tagnumber 0]][[tagnumber 1]]We saw the stock of TapImmune Inc. (OTCMKTS:TPIV) climb up the charts in the beginning of April, but it quickly came crashing down, dropping below the levels before the upward run. The end of the month saw another ascent, but that was followed by the next correction.[[tagnumber 2]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 0]]The last press release that [[tagnumber 6]]TPIV[[tagnumber 7]] has made dates back to April 28 and the lack of news seems to be having a bad effect on the company stock. Meanwhile, the numbers contained in the company’s financial report for the fiscal 2015 look pretty decent compared to other OTC entities with bigger valuations.[[tagnumber 2]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 11]] [[tagnumber 12]]cash: $6.57 million[[tagnumber 13]] [[tagnumber 12]]current assets: $6.64 million[[tagnumber 13]] [[tagnumber 12]]current liabilities: $28 million[[tagnumber 13]] [[tagnumber 12]]revenues: ZERO[[tagnumber 13]] [[tagnumber 12]]loss from operations: $6.15 million[[tagnumber 13]] [[tagnumber 22]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 0]]Those numbers aren’t that bad, but [[tagnumber 6]]TPIV[[tagnumber 7]] is still a long way from generating any revenues, let alone achieving profitability. This, couple with the lack of press releases are some of the reasons for which [[tagnumber 6]]TPIV[[tagnumber 7]] can’t seem to hold on to its value.[[tagnumber 2]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 0]]Last week ended with another 7.35% slip and [[tagnumber 6]]TPIV[[tagnumber 7]] closed Friday’s session with a price of $0.565. There were a total of 1.66 million traded shares that generated $887 thousand in daily dollar volume, one of the biggest on the OTC marketplace.[[tagnumber 2]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 0]]Today’s session isn’t going all that well, either. [[tagnumber 6]]TPIV[[tagnumber 7]] already slipped to a low at 53 cents per share, but has managed to regain some of the lost value. Be sure to do your due diligence and weigh out the risks before putting any money on the line.[[tagnumber 2]]